| Literature DB >> 27942279 |
Yutaka Suzuki1, Naruo Kawasaki1, Mitsuyoshi Urashima2, Hironori Odaira1, Takuji Noro1.
Abstract
BACKGROUND: In clinical settings, early total enteral nutrition (TEN) is known to reduce the postoperative complication and infection rate as well as duration of postoperative stay compared with total parenteral nutrition (TPN) in a variety of critical conditions. We aimed to compare effects TEN and TPN on wound healing and explore its possible mechanisms using rat model.Entities:
Keywords: Cytokine; Rats; Total enteral nutrition; Total parenteral nutrition; Wound healing
Year: 2009 PMID: 27942279 PMCID: PMC5139746 DOI: 10.4021/gr2009.08.1307
Source DB: PubMed Journal: Gastroenterology Res ISSN: 1918-2805
Components of nutrients used for TEN or TPN (/100 kcal)
| Component | TEN*1 | TPN*2 | |
|---|---|---|---|
| Carbohydrate | 14.68 g | 20.59 g | |
| Lipid | LCT | 0.812 g | 0.374 g |
| MCT | 1.968 g | 0 g | |
| Amino acid | 4.05 g | 3.53 g | |
| Total nitrate | 0.6 g | 0.55 g | |
| Volume | 100 ml | 120 ml | |
| Calorie/N | 176 | 182 | |
| Calorie of non protein | 83.7 kcal | 85.9 kcal | |
| Calorie of non protein/N | 140 | 157 |
*1: Twinline® (Otsuka co. ltd, Tokyo, Japan)
*2: Unicaliq® (N) + Multamin®+ Mineralin® + Intrafat® (20%) + 20% Chorine chloride
Figure 1Comparison of bodyweight changes among TEN, TPN, and normal groups. Changes were calculated as bodyweight at day 28/ bodyweight at day 0 (%). Statistical difference was evaluated with Man Whitney U test.
Effects of TEN on nutrition
| Biomarker | TEN | TPN*2 | Control*3 | Kruskal-Wallis *1 |
|---|---|---|---|---|
| Medication nitrogen quantity | 947.8 ± 27.3 | 881.2 ± 15.1‡ | 1515.7 ± 8.1‡ | 0.0001 |
| Urine inside nitrogen quantity | 659.2 ± 63.6 | 755.1 ± 73.2† | 625.4 ± 42.1‡ | 0.0077 |
| Feces inside nitrogen quantity | 62.2 ± 30.7 | 22.9 ± 8.6† | 365.4 ± 7.1‡ | < 0.0001 |
| Nitrogen accounts | 226.3 ± 87.2 | 103.3 ± 80.7† | 524.8 ± 34.9‡ | < 0.0001 |
| Prices | 25.3 ± 9.1 | 11.9 ± 9.3† | 45.6 ± 3.3‡ | < 0.0001 |
| Total protein (g/dl) | 5.4 ± 0.3 | 5.3 ± 0.4 | 4.9 ± 0.2‡ | 0.0004 |
| Albumin (g/dl) | 1.8 ± 0.1 | 1.8 ± 0.1 | 2.2 ± 0.1‡ | < 0.0001 |
| Transferrin (mg/ml) | 3.19 ± 0.41 | 3.13 ± 0.62 | 3.16 ± 0.50‡ | 0.0005 |
*1: Statistical differences were calculated based on Kruskal-Wallis equality of populations rank test. Statistical significance was defined when p-value was less than 0.05.
*2: Value of TPN was compared with TEN by correcting with Bonferroni.
*3: Value of control was compared with TEN.: † p < 0.016, ‡: p < 0.005.
Figure 2Difference of burned area at day 0 (left panel) and day 28 (right panel) between TPN (upper) and TEN (lower).
Figure 3Changes of burned area: burned area at day 28 divided by wound area at day 0 (%) in either TPN or TEN. Statistical difference was evaluated with Man Whitney U test.
Figure 4Comparison of weights of small intestine at day 28 among TPN, EN and control group. Statistical difference was evaluated with Man Whitney U test.
Figure 5Hematoxylin and eosin staining of jejunum obtained from TEN (left panel) and TPN (right panel).
Figure 6Comparison of ratio: length of villi divided by depth of crypt in jejunum among TPN, EN and control group. Statistical difference was evaluated with Man Whitney U test.
Figure 7Association between weight of small bowel and prices. Line and gray area are showing linear regression and 95% confidence interval, respectively.
Effects of TEN on inflammation
| Types | Biomarker | TEN | TPN | Control | Kruskal-Wallis *1 |
|---|---|---|---|---|---|
| Immune | Sialic acid (mg/dl) | 109.6 ± 12.2 | 125.5 ± 21.5 | 75.6 ± 6.8‡ | < 0.0001 |
| IL-4 (pg/ml) | 5.4 ± 8.3 | 10.6 ± 12.7 | 9.7 ± 10.6 | NS | |
| IL-6 (pg/ml) | 2.4 ± 6.7 | 56.7 ± 91.6 | 0 ± 0 | 0.0061 | |
| IL-8 (pg/ml) | 193.2 ± 144.0 | 283.5 ± 277.0 | 122.8 ± 46.4 | NS | |
| IL-10 (pg/ml) | 3.6 ± 9.8 | 18.2 ± 42.4 | 3.9 ± 13.4 | NS | |
| TNF-α (pg/ml) | 1.7 ± 4.2 | 3.9 ± 4.1‡ | 1.3 ± 1.7 | 0.0087 | |
| Endotoxin (pg/ml) | 18.5 ± 6.2 | 20.1 ± 6.1 | 5.7 ± 1.5 | 0.0012 | |
| Spleen (g/100g bodyweight) | 0.25 ± 0.03 | 0.71 ± 0.40‡ | 0.22 ± 0.03 | < 0.0001 | |
| Liver | AST (U/l) | 129.0 ± 42.1 | 567.5 ± 1005.2*2 | 327.0 ± 698.6 | NS |
| ALT (U/l) | 36.4 ± 9.4 | 92.1 ± 145.6 | 30.7 ± 7.5 | NS | |
| Alkaliphosphatase (U/l) | 360.5 ± 74.4 | 569.1 ± 222.8‡ | 491 ± 109.4 | 0.0012 | |
| LAP (IU/l) | 54.6 ± 1.5 | 70.1 ± 25.5 | 71.6 ± 6.1† | 0.0066 | |
| Direct bilirubin (mg/dl) | 0.113 ± 0.057 | 0.196 ± 0.117‡ | 0.088 ± 0.016 | 0.0018 | |
| Indirect bilirubin (mg/dl) | 0.015 ± 0.014 | 0.055 ± 0.075† | 0.030 ± 0.012 | NS | |
| Renal | BUN (mg/dl) | 18.5 ± 2.3 | 22.7 ± 4.5‡ | 16.4 ± 15.5 | < 0.0001 |
| Cr (mg/dl) | 0.46 ± 0.05 | 0.55 ± 0.08‡ | 0.42 ± 0.05 | < 0.0001 | |
| Metabolism | Glucose (mg/dl) | 157.3 ± 5.5 | 116.8 ± 32.7‡ | 141.9 ± 17.5 | 0.0004 |
| Triglyceride (mg/dl) | 51.8 ± 19.6 | 23.1 ± 11.1‡ | 35.8 ± 17.3† | 0.0002 | |
| Total cholesterol (mg/dl) | 60.8 ± 11.5 | 55.5 ± 10.4 | 54.0 ± 10.8 | NS |
*1: Statistical differences were calculated based on Kruskal-Wallis equality of populations rank test. Statistical significance was defined when p-value was less than 0.05. *2. Two high levels of AST (2864, 2994) were included in TPN group. †: p < 0.016, ‡: p < 0.005.